Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
and pharmaceutical giant Pfizer (PFE), has set its sights on Kenvue (KVUE). The Wall Street Journal reported Starboard ...
Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc KVUE, the company behind popular consumer products like Tylenol and Listerine. Despite having some ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback